Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma

1. Zugasti, I.
2. Tormo-Ratera, M.
3. Oliver-Caldés, A.
4. Soler-Perromat, J.C.
5. González-Calle, V.
6. Moreno, D.F.
7. Cabañas, V.
8. López-Muñoz, N.
9. Bartolomé-Solanas, Á.
10. Español-Rego, M.
11. Reguera-Ortega, J.L.
12. Rosiñol, L.
13. López-Corral, L.
14. Tovar, N.
15. Rodríguez-Lobato, L.G.
16. Alvarez Perez, R.M.
17. Varea, S.
18. Olesti, E.
19. Gomez-Grande, A.
20. Frutos, L.
21. Tamayo, P.
22. Juan, M.
23. Moraleda, J.M.
24. Urbano-Ispizua, Á.
25. González-Navarro, E.A.
26. Martínez-López, J.
27. Mateos, M.-V.
28. Tomás, X.
29. Setoain, X.
30. Fernández de Larrea, C.
31. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1182/BLOODADVANCES.2024014360 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus